BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The BCG vaccine, widely used in Brazil in new-borns, induces adjuvant protection for several diseases, including childhood virus infections. BCG activates monocytes and innate memory NK cells which are crucial for the antiviral immune response. Therefore, strategies to prevent COVID-19 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Junqueira-Kipnis, Ana Paula, dos Anjos, Laura Raniere Borges, Barbosa, Lília Cristina de Souza, da Costa, Adeliane Castro, Borges, Kellen Christina Malheiros, Cardoso, Amanda da Rocha Oliveira, Ribeiro, Kaio Mota, Rosa, Sarah Brena Aparecida, Souza, Carine de Castro, das Neves, Rogério Coutinho, Saraiva, Guylherme, da Silva, Sueli Meira, da Silveira, Erika Aparecida, Rabahi, Marcelo Fouad, Conte, Marcus Barreto, Kipnis, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586662/
https://www.ncbi.nlm.nih.gov/pubmed/33106170
http://dx.doi.org/10.1186/s13063-020-04822-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586662/
https://www.ncbi.nlm.nih.gov/pubmed/33106170
http://dx.doi.org/10.1186/s13063-020-04822-0

Ejemplares similares